Legend Biotech LEGN
NASDAQ LEGN
$19.89 +1.07 (+5.69%)
At close: Sep 30, 2026 · 4:00 PM EDT

Legend Biotech (LEGN) Short term Debt (2025 - 2026)

Updated

Legend Biotech (LEGN) posted Short term Debt of $156.4 million for Q2 2026, down 41.2% from the prior quarter.

Analysis

Legend Biotech (LEGN) Short term Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Legend Biotech's Short term Debt came in at $319.1 million.

  • Quarterly Short term Debt has run from a low of $142.9 million in Q3 2025 to a high of $319.1 million in Q4 2025 over five years.
  • According to Business Quant data, Short term Debt for the three prior quarters was $266 million (Q1 2026), $319.1 million (Q4 2025) and $142.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Legend Biotech 3.67 Bn -74.25 Mn 251.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156.40 Mn
Mar 31, 2026 266.00 Mn
Dec 31, 2025 319.10 Mn
Sep 30, 2025 142.90 Mn
API Access

Legend Biotech Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=LEGN&period=max&api_key=YOUR_API_KEY